Clonality of CD4(+) Blood T Cells Predicts Longer Survival With CTLA4 or PD-1 Checkpoint Inhibition in Advanced Melanoma

por Arakawa, Akiko, Vollmer, Sigrid, Tietze, Julia, Galinski, Adrian, Heppt, Markus V., Bürdek, Maja, Berking, Carola, Prinz, Jörg C.
Publicado 2019

Head-to-Head Comparison of BRAF/MEK Inhibitor Combinations Proposes Superiority of Encorafenib Plus Trametinib in Melanoma

por Schulz, Alexander, Raetz, Jennifer, Karitzky, Paula C., Dinter, Lisa, Tietze, Julia K., Kolbe, Isabell, Käubler, Theresa, Renner, Bertold, Beissert, Stefan, Meier, Friedegund, Westphal, Dana
Publicado 2022

Bystander memory CD8 T cell proliferation after anti-CD40/IL-2 treatment is independent of CD4 T cells

por Grossenbacher, Steven K, Monjazeb, Arta M, Tietze, Julia, Sckisel, Gail D, Mirsoian, Annie, Hsiao, Hui-Hua, Koehn, Brent, Wilkins, Danice, Blazer, Bruce R, Murphy, William J
Publicado 2013

CTLA4 as Immunological Checkpoint in the Development of Multiple Sclerosis

por Gerdes, Lisa Ann, Held, Kathrin, Beltrán, Eduardo, Berking, Carola, Prinz, Jörg C., Junker, Andreas, Tietze, Julia K., Ertl‐Wagner, Birgit, Straube, Andreas, Kümpfel, Tania, Dornmair, Klaus, Hohlfeld, Reinhard
Publicado 2016

Bystander Activation and Anti-Tumor Effects of CD8+ T Cells Following Interleukin-2 Based Immunotherapy Is Independent of CD4+ T Cell Help

por Monjazeb, Arta M., Tietze, Julia K., Grossenbacher, Steven K., Hsiao, Hui-Hua, Zamora, Anthony E., Mirsoian, Annie, Koehn, Brent, Blazar, Bruce R., Weiss, Jonathan M., Wiltrout, Robert H., Sckisel, Gail D., Murphy, William J.
Publicado 2014

The efficacy of re-challenge with BRAF inhibitors after previous progression to BRAF inhibitors in melanoma: A retrospective multicenter study

por Tietze, Julia K., Forschner, Andrea, Loquai, Carmen, Mitzel-Rink, Heidrun, Zimmer, Lisa, Meiss, Frank, Rafei-Shamsabadi, David, Utikal, Jochen, Bergmann, Maike, Meier, Friedegund, Kreuzberg, Nicole, Schlaak, Max, Weishaupt, Carsten, Pföhler, Claudia, Ziemer, Mirjana, Fluck, Michael, Rainer, Jessica, Heppt, Markus V., Berking, Carola
Publicado 2018

Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients

por Amaral, Teresa, Kiecker, Felix, Schaefer, Sarah, Stege, Henner, Kaehler, Katharina, Terheyden, Patrick, Gesierich, Anja, Gutzmer, Ralf, Haferkamp, Sebastian, Uttikal, Jochen, Berking, Carola, Rafei-Shamsabadi, David, Reinhardt, Lydia, Meier, Friedegund, Karoglan, Ante, Posch, Christian, Gambichler, Thilo, Pfoehler, Claudia, Thoms, Kai, Tietze, Julia, Debus, Dirk, Herbst, Rudolf, Emmert, Steffen, Loquai, Carmen, Hassel, Jessica C, Meiss, Frank, Tueting, Thomas, Heinrich, Vanessa, Eigentler, Thomas, Garbe, Claus, Zimmer, Lisa
Publicado 2020